Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Myocardial 123I-MIBG Scintigraphy in Aging and Neurodegenerative Disease

Authors not listed

Mayo Clinic · 2023

Abstract

The purpose of the study is to investigate the use of a special radioactive drug called 123I-MIBG and myocardial MIBG scintigraphy. This scan may be able to help determine who may have a certain kind of neurologic disorder called Lewy Body Disease. The overall purpose of this study is to correlate myocardial MIBG scintigraphy findings with clinical diagnosis. Myocardial MIBG scintigraphy imaging will be combined with other clinical, neuropsychological and neuroimaging findings to improve the prediction for underlying Lewy Body Disease.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-29 MST

Cite this

APA
Anonymous. (2023). Myocardial 123I-MIBG Scintigraphy in Aging and Neurodegenerative Disease. <em>Mayo Clinic</em>. https://clinicaltrials.gov/study/NCT05514106
Vancouver
Anonymous. Myocardial 123I-MIBG Scintigraphy in Aging and Neurodegenerative Disease. Mayo Clinic. 2023.
BibTeX
@misc{anon2023Myocar, title = {Myocardial 123I-MIBG Scintigraphy in Aging and Neurodegenerative Disease}, author = {Anonymous}, journal = {Mayo Clinic}, year = {2023}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings